115
Zevra Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
92.8
FY23:
86.9
FY24:
86.0
FY25:
223
(positive)
Change from FY21 to FY25
millions USD
FY21:
17.9
FY22:
22.5
FY23:
85.4
FY24:
92.1
FY25:
61.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
133
FY22:
115
FY23:
172
FY24:
178
FY25:
285
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.23
FY22:
12.0
FY23:
73.7
FY24:
34.1
FY25:
39.3
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.59
FY22:
28.2
FY23:
36.7
FY24:
104
FY25:
90.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
127
FY22:
75.1
FY23:
61.9
FY24:
39.7
FY25:
155
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
133
FY22:
115
FY23:
172
FY24:
178
FY25:
285
All amounts in millions USD